Oral Solid Dosage Pharmaceutical Formulation Market

Global Oral Solid Dosage Pharmaceutical Formulation Market: By Product Type (Tablets, Lozenges, Capsules), By Drug Release Mechanism (Sustained Release, Extended Release, Instant Release, Chewable Tablets, Effervescent Tablets, Enteric Release), By Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), and Geography — Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013–2017 and Forecast 2018–2023
Global oral solid dosage pharmaceutical formulation market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024.
Market Outline: Oral Solid Dosage Pharmaceutical Formulation Market
Oral solid dosage pharmaceutical formulation are most widely used dosage forms. They are easy to manufacture and transport due to its increased chemical and physical stability. The Oral solid dosage formulations are cost effective when compared with the other kind of dosage forms. These can be formulated in various flavors in order to mask the unpleasant taste of the formulation and increase the patient compliance. The technological advancements are enabling the manufacturers to formulate new drugs such as sustained release dosage forms which minimize the frequent administration of the drug.
Market Dynamics: Oral Solid Dosage Pharmaceutical Formulation Market
Market players are majorly focused on oral solid dosage forms due to convenience and safe way of administration. Increased sedentary and fast paced lifestyle is leading to adopt lifestyle related diseases such as obesity, diabetes. The manufacturers are targeting the population in developing countries in order to enhance the market. A significant boost is observed in the Asia Pacific region owing to increased population. Moreover, the generic manufacturers are playing a major role in the growth of the oral solid dosage pharmaceutical formulation market by introducing generic drugs in the local market. However, the high regulatory requirement is expected to hamper the market.
Free sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/oral-solid-dosage-pharmaceutical-formulation-market/#ulp-4H8Z4LpNMLEuOnnx
Market Scope: Oral Solid Dosage Pharmaceutical Formulation Market
Oral solid dosage pharmaceutical formulation market is segmented based on the type, drug release mechanism, and distribution channel
Based on the type, the market is segmented into the following:
· Tablets
· Lozenges
· Capsules
o Hard Gelatin Capsules
o Soft Gelatin Capsules
Based on the Drug Release Mechanism, the market is segmented into the following:
· Sustained Release
· Extended Release
· Instant Release
· Chewable Tablets
· Effervescent Tablets
· Enteric Release
Based on the distribution channel, the market is segmented into the following:
· Hospital Pharmacies
· Retail Pharmacies
· Drug Stores
· Online Pharmacies
Free TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/oral-solid-dosage-pharmaceutical-formulation-market/#ulp-c654SbFYO64MsOhu
Regional Analysis: Oral Solid Dosage Pharmaceutical Formulation Market
Geographically, global oral solid dosage pharmaceutical formulation market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America dominates the oral solid dosage pharmaceutical formulation market and expected to grow at significant CAGR over the forecasted period. North America being more lucrative showing the higher expectancy of market growth. Asia Pacific oral solid dosage pharmaceutical formulation market is expected to show higher growth rate. The emerging countries such as India and China are showing a significant growth due to the entry of local market players which formulate the generic drugs.
Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/oral-solid-dosage-pharmaceutical-formulation-market/#ulp-14mlyhjMGhVjZqa3
Competition Assessment: Oral Solid Dosage Pharmaceutical Formulation Market
Some of the players in the global oral solid dosage pharmaceutical formulation market include:
· AstraZeneca Plc. (UK)
· Bristol-Myers Squibb Company (U.S)
· Novartis AG (Switzerland)
· Pfizer Inc. (U.S)
· AbbVie Inc. (U.S)
· Boehringer Ingelheim GmbH (Germany)
· Johnson & Johnson (U.S)
· Merck & Co. Inc. (U.S)
· Gilead Sciences (U.S)
Notable Market Developments: Oral Solid Dosage Pharmaceutical Formulation Market
Ø In Feburary 2018, Colorcon, Inc., has introduced the Opadry EZ, Easy Swallow Film Coating System, a new product aimed at addressing the difficulty faced by many patients in swallowing oral solid dosage forms.
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/oral-solid-dosage-pharmaceutical-formulation-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152–160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1–866–598–1553
Website @https://www.precisionbusinessinsights.com